Aberrant sensing of extracellular Ca2+ by cultured ataxia telangiectasia fibroblasts.

Abstract:

:Ataxia telangiectasia (AT) is a human hereditary syndrome whose underlying gene product, ataxia telangiectasia mutated (ATM) protein kinase, is involved in multiple intracellular signaling pathways. We demonstrated previously that AT fibroblasts are defective in intracellular Ca(2+) mobilization in response to both stress-inducing and mitogenic stimuli. To extend these findings, normal and AT cells were exposed to serum in the presence of different concentrations of extracellular Ca(2+) ([Ca(2+)](o)), and release of intracellular Ca(2+), activation of calmodulin-dependent protein kinase II and phosphorylation of kinases ERK1 and 2 were monitored. When maintained in high [Ca(2+)](o) (0.42 mM), normal fibroblasts responded to serum introduction more rapidly and efficiently than did AT cells. Unexpectedly, decreasing the [Ca(2+)](o) in the medium had a diametrically opposite effect. Under low [Ca(2+)](o) (0.0022 mM) conditions, normal cells were slow and inefficient in their responses, whereas AT cells showed a substantial improvement in all three end points. These findings demonstrate that loss of ATM kinase function deregulates the extracellular calcium-sensing receptor (CaR). This malfunction presumably arises from a post-transcriptional event, since CaR mRNA proved to be normal in AT cells. Together, our data suggest that ATM may mediate cell response to mitogenic factors by tightly regulating the set point of the CaR and thereby modulating the crosstalk between this metabotropic receptor and growth factor receptors. Alternatively, the faulty sensing of extracellular calcium in AT cells may be secondary to a state of chronic oxidative stress attributable to ATM deficiency.

journal_name

Oncogene

journal_title

Oncogene

authors

Famulski KS,Al-Hijailan RS,Dobler K,Pienkowska M,Al-Mohanna F,Paterson MC

doi

10.1038/sj.onc.1206167

subject

Has Abstract

pub_date

2003-01-23 00:00:00

pages

471-5

issue

3

eissn

0950-9232

issn

1476-5594

pii

1206167

journal_volume

22

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Non-selective analysis of the transformation of FR3T3 rat cells by bovine papillomavirus type 1: regulations of viral transcription associated with phenotypic transformation.

    abstract::Drug-resistant clones selected from FR3T3 rat cells after transfer of neo-BPV1 (Bovine Papillomavirus Type 1) DNA constructs became phenotypically transformed (focal transformation, growth in suspension and tumor formation) soon after selection (approximately 5 generations in culture). A frameshift mutation in ORF E5 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Binétruy B,Schiller J,Lowy D,Cerni C,Cuzin F

    更新日期:1990-11-01 00:00:00

  • Mutation of GATA3 in human breast tumors.

    abstract::GATA3 is an essential transcription factor that was first identified as a regulator of immune cell function. In recent microarray analyses of human breast tumors, both normal breast luminal epithelium and estrogen receptor (ESR1)-positive tumors showed high expression of GATA3. We sequenced genomic DNA from 111 breast...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207966

    authors: Usary J,Llaca V,Karaca G,Presswala S,Karaca M,He X,Langerød A,Kåresen R,Oh DS,Dressler LG,Lønning PE,Strausberg RL,Chanock S,Børresen-Dale AL,Perou CM

    更新日期:2004-10-07 00:00:00

  • Mouse models in the study of the Ets family of transcription factors.

    abstract::The Ets family of transcription factors is one of a growing number of master regulators of development. This family was originally defined by the presence of a conserved DNA binding domain, the Ets domain. To date, nearly 30 members of this family have been identified and implicated in a wide range of physiological an...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204038

    authors: Bartel FO,Higuchi T,Spyropoulos DD

    更新日期:2000-12-18 00:00:00

  • Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.

    abstract::Secreted frizzled related protein 1 (SFRP 1) is an antagonist of the transmembrane frizzled receptor, a component of the Wnt signaling pathway, and has been suggested to be a candidate tumor suppressor in several human malignancies. Since SFRP 1 is located at chromosome 8 p 11, where lung cancers also exhibit frequent...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208777

    authors: Fukui T,Kondo M,Ito G,Maeda O,Sato N,Yoshioka H,Yokoi K,Ueda Y,Shimokata K,Sekido Y

    更新日期:2005-09-15 00:00:00

  • Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.

    abstract::The human c-rel gene (REL), encoding an NF-kappaB transcription factor, is amplified or mutated in several human B-cell lymphomas and can transform chicken lymphoid cells in vitro. We have previously shown that certain deletions of C-terminal transactivation sequences enhance REL's transforming ability in chicken sple...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208902

    authors: Starczynowski DT,Reynolds JG,Gilmore TD

    更新日期:2005-11-10 00:00:00

  • Shc3 affects human high-grade astrocytomas survival.

    abstract::A selective switch from expression of Shc1 gene to Shc3 occurs with maturation of neuronal precursors into postmitotic neurons. Previous studies showed that in the embryo, Shc1 is maximally expressed in dividing CNS stem cells while it is silenced in mature neurons, where it is replaced by Shc3. Under normal condition...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208708

    authors: Magrassi L,Conti L,Lanterna A,Zuccato C,Marchionni M,Cassini P,Arienta C,Cattaneo E

    更新日期:2005-08-04 00:00:00

  • How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

    abstract::Cancer cells enhance their glycolysis, producing lactate, even in the presence of oxygen. Glycolysis is a series of ten metabolic reactions catalysed by enzymes whose expression is most often increased in tumour cells. HKII and phosphoglucose isomerase (PGI) have mainly an antiapoptotic effect; PGI and glyceraldehyde-...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2014.320

    authors: Lincet H,Icard P

    更新日期:2015-07-01 00:00:00

  • EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer.

    abstract::EDD (E3 isolated by differential display), located at chromosome 8q22.3, is the human orthologue of the Drosophila melanogaster tumour suppressor gene 'hyperplastic discs' and encodes a HECT domain E3 ubiquitin protein-ligase. To investigate the possible involvement of EDD in human cancer, several cancers from diverse...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206775

    authors: Clancy JL,Henderson MJ,Russell AJ,Anderson DW,Bova RJ,Campbell IG,Choong DY,Macdonald GA,Mann GJ,Nolan T,Brady G,Olopade OI,Woollatt E,Davies MJ,Segara D,Hacker NF,Henshall SM,Sutherland RL,Watts CK

    更新日期:2003-08-07 00:00:00

  • AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.

    abstract::Accumulating evidences have shown the association between aberrantly expressed microRNAs (miRs) and cancer, where these small regulatory RNAs appear to dictate the cell fate by regulating all the main biological processes. We demonstrated the responsibility of the circuitry connecting the oncomiR-221&222 with the tumo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.357

    authors: Felli N,Errico MC,Pedini F,Petrini M,Puglisi R,Bellenghi M,Boe A,Felicetti F,Mattia G,De Feo A,Bottero L,Tripodo C,Carè A

    更新日期:2016-06-09 00:00:00

  • Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation.

    abstract::Ras genes, frequently mutated in human tumors, promote malignant transformation. Ras transformation requires membrane anchorage, which is promoted by Ras farnesylcysteine carboxymethylester and by a second signal. Previously we showed that the farnesylcysteine mimetic, farnesylthiosalicylic acid (FTS) disrupts Ras mem...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204950

    authors: Paz A,Haklai R,Elad-Sfadia G,Ballan E,Kloog Y

    更新日期:2001-11-08 00:00:00

  • The binding of transcription factor Sp1 to multiple sites is required for maximal expression from the rat transforming growth factor alpha promoter.

    abstract::Transcription from the rat transforming growth factor alpha (TGF-alpha) promoter initiates at multiple sites within a 200-bp G+C-rich region that lacks TATA and CAAT motifs but contains multiple potential binding sites for the transcription factor Sp1. In the present study, we used deletion analysis to establish the 5...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Chen X,Azizkhan JC,Lee DC

    更新日期:1992-09-01 00:00:00

  • Mimicking the BH3 domain to kill cancer cells.

    abstract::Cancer cells show deviant behavior that induces apoptotic signaling. To survive, cancer cells typically acquire changes enabling evasion of death signals. One way they do this is by increasing the expression of anti-apoptotic BCL-2 proteins. Anti-apoptotic BCL-2 family proteins antagonize death signaling by forming he...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2009.52

    authors: Ni Chonghaile T,Letai A

    更新日期:2008-12-01 00:00:00

  • Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.

    abstract::Retinoids have been shown to inhibit the growth of a number of human tumor cells, including several ovarian adenocarcinoma cell lines. All-trans retinoic acid (RA) is an effective growth suppressor of CA-OV3 cells but not SK-OV3 cells. Since the effects of RA are known to be mediated via the nuclear receptors (RARs an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202208

    authors: Wu S,Zhang D,Zhang ZP,Soprano DR,Soprano KJ

    更新日期:1998-12-03 00:00:00

  • Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16.

    abstract::P16 was originally discovered by its ability to interact with CDK4 and to specifically inhibit the catalytic activity of the CDK4/D1 kinase. Increased attention has focused on the p16 gene because of its location on chromosome 9p21, a region involved in chromosomal rearrangements in a large number of tumor types. The ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wick ST,Dubay MM,Imanil I,Brizuela L

    更新日期:1995-11-16 00:00:00

  • Involvement of poly (ADP-ribose)-polymerase in the Pax-6 gene regulation in neuroretina.

    abstract::The quail Pax-6 gene is expressed from two promoters named P0 and P1. P0 promoter is under the control of a neuroretina-specific enhancer (EP). This enhancer activates the P0 promoter specifically in neuroretina cells and in a developmental stage-dependent manner. The EP enhancer binds efficiently, as revealed by sout...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202406

    authors: Plaza S,Aumercier M,Bailly M,Dozier C,Saule S

    更新日期:1999-01-28 00:00:00

  • Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.

    abstract::Platelet-derived growth factor (PDGF) and vascular endothelial growth factor define a family of dimeric proteins characterized by eight conserved cysteine residues involved in disulfide bonds. Thirteen non-cysteine residues conserved among the platelet-derived/vascular endothelial growth factors were individually muta...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maher DW,Strawn LM,Donoghue DJ

    更新日期:1993-03-01 00:00:00

  • The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.

    abstract::The BCL6 gene, mapped at the chromosomal band 3q27, encodes a POZ/Zinc finger transcription repressor protein. It is frequently activated in Non-Hodgkin's lymphomas (NHL) by translocations with breakpoints clustering in the 5' major breakpoint region (MBR) as well as by mutations in the same region. The translocations...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202098

    authors: Chen W,Butler M,Rao PH,Chaganti SR,Louie DC,Dalla-Favera R,Chaganti RS

    更新日期:1998-10-01 00:00:00

  • GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21.

    abstract::KLF6, a ubiquitously expressed Krüppel-like transcription factor, is frequently inactivated in human cancer and has significant roles in cellular proliferation, apoptosis, differentiation and development. A key mechanism of KLF6-mediated growth suppression is through p53-independent transactivation of p21. Several can...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.457

    authors: Lang UE,Kocabayoglu P,Cheng GZ,Ghiassi-Nejad Z,Muñoz U,Vetter D,Eckstein DA,Hannivoort RA,Walsh MJ,Friedman SL

    更新日期:2013-09-19 00:00:00

  • Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways.

    abstract::Overexpression of hepatocyte growth factor (HGF), also called scatter factor (SF), and its receptor c-Met are associated with poor prognosis for cancer patients. In particular, breast cancer cells can produce HGF that acts in a paracrine as well as in an autocrine manner. Therefore, HGF and c-Met are putative targets ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207063

    authors: Gallego MI,Bierie B,Hennighausen L

    更新日期:2003-11-20 00:00:00

  • Polyomavirus large T-antigen protects mouse cells from Fas-, TNF-alpha- and taxol-induced apoptosis.

    abstract::Polyomavirus large T-antigen (PyLT-Ag), a nucleophosphoprotein essential for regulating viral gene expression, modulates the cell cycle by binding to the Rb tumor suppressor gene product. PyLT-Ag/Rb binding is essential for in vitro immortalization. However, the effect of PyLT-Ag on apoptosis has not been extensively ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204015

    authors: Rodier F,Bertrand R,Bossolasco M,Mes-Masson AM

    更新日期:2000-12-14 00:00:00

  • Wn mutation of c-kit receptor affects its post-translational processing and extracellular expression.

    abstract::The W locus of mice encodes the c-kit receptor tyrosine kinase. Recently, we characterized a novel mutant allele, Wn, and demonstrated that the c-kit protein synthesized in Wn/Wn cultured mast cells (CMC) was reduced in size and not expressed on their surface (Tsujimura et al., 1993). In this study, we further examine...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Koshimizu U,Tsujimura T,Isozaki K,Nomura S,Furitsu T,Kanakura Y,Kitamura Y,Nishimune Y

    更新日期:1994-01-01 00:00:00

  • Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b.

    abstract::Cbl proteins are ubiquitin protein ligases, which ubiquitinate activated tyrosine kinases and target them for degradation. Both c-Cbl and Cbl-b have an ubiquitin associated (UBA) domain at their C-terminal end. We observed that high molecular weight ubiquitinated proteins constitutively coimmunoprecipitated with trans...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207952

    authors: Davies GC,Ettenberg SA,Coats AO,Mussante M,Ravichandran S,Collins J,Nau MM,Lipkowitz S

    更新日期:2004-09-16 00:00:00

  • Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.

    abstract::Matrix metalloprotease-1 (MMP1) is an important mediator of tumorigenesis, inflammation and tissue remodeling through its ability to degrade critical matrix components. Recent studies indicate that stromal-derived MMP1 may exert direct oncogenic activity by signaling through protease-activated receptor-1 (PAR1) in car...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.157

    authors: Foley CJ,Fanjul-Fernández M,Bohm A,Nguyen N,Agarwal A,Austin K,Koukos G,Covic L,López-Otín C,Kuliopulos A

    更新日期:2014-04-24 00:00:00

  • Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.

    abstract::A hallmark of cancer is the deregulation of cell-cycle machinery, ultimately facilitating aberrant proliferation that fuels tumorigenesis and disease progression. Particularly, in breast cancers, cyclin D1 has a crucial role in the development of disease. Recently, a highly specific inhibitor of CDK4/6 activity (PD-03...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.154

    authors: Dean JL,Thangavel C,McClendon AK,Reed CA,Knudsen ES

    更新日期:2010-07-15 00:00:00

  • Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

    abstract::The human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus discovered to be causative of a human cancer, adult T-cell leukemia. The transforming entity of HTLV-1 has been attributed to the virally-encoded oncoprotein, Tax. Unlike the v-onc proteins encoded by other oncogenic animal retroviruses that tran...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.537

    authors: Matsuoka M,Jeang KT

    更新日期:2011-03-24 00:00:00

  • JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress.

    abstract::Ferritin is the major intracellular iron storage protein that sequesters excess free iron to minimize generation of iron-catalysed reactive oxygen species. We previously demonstrated that expression of ferritin heavy chain (ferritin H) was induced by pro-oxidants, which is a part of cellular antioxidant response to pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208901

    authors: Tsuji Y

    更新日期:2005-11-17 00:00:00

  • Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.

    abstract::tal-1 deletions are caused by a site specific recombination, which exclusively occurs in 12-26% of T-cell acute lymphoblastic leukemias (T-ALL). In a previous study on a large series of T-ALL we demonstrated an apparent preferential occurrence of tal-1 deletions in CD3- and CD3+ alpha beta lineage T-ALL with TcR-delta...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Breit TM,Wolvers-Tettero IL,van Dongen JJ

    更新日期:1994-07-01 00:00:00

  • Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.

    abstract::We studied loss of heterozygosity (LOH) in chromosome 7q in order to determine the location of a putative tumor suppressor gene (TSG) in human epithelial ovarian carcinomas. Samples were obtained from 26 primary ovarian carcinomas at the time of staging laparotomy. Paired normal and tumoral DNAs were used as templates...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zenklusen JC,Weitzel JN,Ball HG,Conti CJ

    更新日期:1995-07-20 00:00:00

  • A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4.

    abstract::In a previous work we provided preliminary evidence of the existence of a putative tumor suppressor gene region on the distal part of chromosome 4 in gamma-radiation-induced T-cell lymphomas of (C57BL/6J x RF/J) F1 hybrid mice. This region, named as TLSR2 (Thymic Lymphoma Suppressor Region 2), was located centered at ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202009

    authors: Santos J,Herranz M,Pérez de Castro I,Pellicer A,Fernández-Piqueras J

    更新日期:1998-08-20 00:00:00

  • FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

    abstract::Targeting Bruton tyrosine kinase (BTK) by ibrutinib is an effective treatment for patients with relapsed/refractory mantle cell lymphoma (MCL). However, both primary and acquired resistance to ibrutinib have developed in a significant number of these patients. A combinatory strategy targeting multiple oncogenic pathwa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.155

    authors: Li Y,Bouchlaka MN,Wolff J,Grindle KM,Lu L,Qian S,Zhong X,Pflum N,Jobin P,Kahl BS,Eickhoff JC,Wuerzberger-Davis SM,Miyamoto S,Thomas CJ,Yang DT,Capitini CM,Rui L

    更新日期:2016-12-01 00:00:00